MedTrace Logo

A Novel, Non-pharmacological, Intervention for the Management of ADHD in Adolescents

NCT05835336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-03-24

Study results available
· View outcomes & findings →

Summary

This is a 2-month study in which eligible ADHD adolescents will be provided with personalized VIZO Glasses

Conditions

  • ADHD

Interventions

DEVICE

VIZO Glasses

Eyeglasses with personalized peripheral retinal stimuli

Sponsors & Collaborators

  • VIZO Specs Ltd

    lead INDUSTRY

Principal Investigators

  • Zohar Elyoseph, PhD · Max Stern Academic College of Emek Yezreel

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-07-06
Completion
2023-07-06

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05835336 on ClinicalTrials.gov